Decentralized Trial Technology Resources

  1. Understanding Decentralized Clinical Trials: FDA vs. EMA Fundamentals 9/15/2025

    Designing a global decentralized clinical trial requires understanding the differing FDA and EMA approaches to trial models and informed consent.

  2. 10 Questions To Ask When Looking For An eClinical Platform 7/2/2024

    Stakeholders should ask these questions when aiming to enhance the integrity and efficiency of their clinical trials while minimizing risks associated with inadequate eClinical solutions.

  3. Repositioning Your CDM Team To Meet Digital Trial Demands 1/25/2023

    Consider these steps when repositioning your clinical data management team to unify cross-functional reviews and align processes and technology to meet the demands of digital trials.

  4. RBQM For Decentralized Trials: Two Key Areas Of Focus To Reduce Your Risk 9/26/2022

    This article takes a more in-depth look at Sections 5.0.5: ‘Risk Communication’ and 5.0.6: ‘Risk Review.’ in ICH-GCP E6 R2 to show how the implementation of RBQM can reduce issues and achieve holistic trial oversight in today’s complex decentralized trials.

  5. The Transformative Impact Of EDC Systems In 2025 5/6/2025

    The shift towards decentralized and hybrid trials underscores the significance of EDC in expanding geographic reach, fostering diversity in participant populations, and reduce participant burden.

  6. Data-Driven Adaptive Trials Enhance Safety, Progress, And Economics 7/21/2023

    By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.

  7. Pitfalls And Possibilities: EHRs To RWD Via EDC 7/5/2023

    Consider DIA GCP & QA Community Chair Terry Katz’s perspective on repurposing and analyzing EHR data for clinical research.

  8. Avoiding Vaporware – Even More Questions To Ask eClinical Platform Providers 8/7/2024

    For a platform that aligns with the demands of modern clinical research, delve into these considerations to ensure your choice supports your study’s success.

  9. Ready For Remote: eCOA Adapts To A Hybrid World 6/2/2022

    Due to the global health impact of COVID-19, many aspects of daily life have been moved to a hybrid model, meaning a mix of in-person and technology-enabled interactions In this blog, learn why eCOAs are especially well-suited for hybrid clinical trials.

  10. How Digital Therapeutics Tools Interact To Improve Patient Care 4/22/2022

    This comprehensive overview illustrates the intersection between prescription digital therapeutics, digital health tools, and decentralized clinical trials in a remote care setting.